0001209191-17-059627.txt : 20171107
0001209191-17-059627.hdr.sgml : 20171107
20171107170742
ACCESSION NUMBER: 0001209191-17-059627
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171107
FILED AS OF DATE: 20171107
DATE AS OF CHANGE: 20171107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hohneker John
CENTRAL INDEX KEY: 0001695378
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37601
FILM NUMBER: 171184300
MAIL ADDRESS:
STREET 1: C/O DIMENSION THERAPEUTICS, INC.
STREET 2: 840 MEMORIAL DRIVE 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dimension Therapeutics, Inc.
CENTRAL INDEX KEY: 0001592288
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 463942159
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 840 MEMORIAL DRIVE
STREET 2: 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-401-0011
MAIL ADDRESS:
STREET 1: 840 MEMORIAL DRIVE
STREET 2: 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-11-07
1
0001592288
Dimension Therapeutics, Inc.
DMTX
0001695378
Hohneker John
C/O DIMENSION THERAPEUTICS, INC.
840 MEMORIAL DRIVE 4TH FLOOR
CAMBRIDGE
MA
02139
1
0
0
0
Stock Option (Right to Buy)
4.60
2017-11-07
4
D
0
38000
D
2027-01-17
Common Stock
38000
0
D
This stock option, which vests annually over three years, beginning January 18, 2017, subject to the director's continued service on the Board, was assumed by Ultragenyx Pharmaceutical Inc. ("Ultragenyx"), and converted in accordance with the exchange ratio as set forth in the Agreement and Plan of Merger (the "Merger Agreement"), dated October 2, 2017, between the Issuer, Ultragenyx and Mystic River Merger Sub Inc., a direct, wholly-owned subsidiary of Ultragenyx.
/s/ Mary Thistle, as Attorney-in-Fact for John Hohneker
2017-11-07